News
Successful track record across oncology therapeutics including ADCs and antibody therapies ranging from early discovery to pre-clinical/clinical stage 25+ year-career experience bolsters Company's ...
1h
Barchart on MSNDo Wall Street Analysts Like Pfizer Stock?Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells ...
Pfizer and Arvinas have axed two phase 3 trials from their estrogen receptor (ER) degrader R&D plan in the wake of mixed data ...
Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...
There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are ...
When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...
17h
Amazon S3 on MSNPfizer Beats Q1 Profit Estimates, Expands Cost-Cutting Plan to Reach $7.7B in Savings by 2027Pfizer expanded its cost-cutting plans and posted first-quarter profit above estimates, despite a decline in sales driven by ...
Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...
Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...
Pfizer Inc. and BioNTech SE failed to knock out any of Alnylam Pharmaceuticals Inc.’s patents in a case over the partners’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results